Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
glp1 gip tirzepatide GLP-1 & Weight Loss Injection In the SYNERGY-NASH trial, Tier:Restore (Advanced) bundle_menopause
In the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly tirzepatide in persons with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or severe fibrosis. Full trial results and Plain Language Summary
2 In fact, all evaluated medications by the manufacturer, including ethinylestradiol and levonorgestrel, resulted in no dose adjustment recommendations
bundle_menopause
Tier:Restore (Advanced)
We track the research and will update patients as the evidence matures
